# clm_9BD72894A2FA

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 22,616,000,000 United States dollar  
valid_from: 2019-06-30  
valid_to: 2019-09-30  
published: 2019-08-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_30E506D439CD  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 22,616,000,000 United States dollar", as of 2019-06-30 (until 2019-09-30). Claim clm_9BD72894A2FA, https://asof.is/claim/clm_9BD72894A2FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209519000020/0000882095-19-000020-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2019-08-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209519000020/0000882095-19-000020-index.htm (primary, SEC EDGAR 10-Q Q2 FY2019, published 2019-08-06)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 21,951,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_9BD72894A2FA](/claim/clm_9BD72894A2FA.md) | [clm_427FE77026B1](/claim/clm_427FE77026B1.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.